COMPANIES COVERED
Sanofi AventisDownload FREE Report Sample
Download Free sampleFurosemide, sold under the brand name Lasix among others, is a medication used to treat fluid build-up due to heart failure, liver scarring, or kidney disease.
Furosemide Market contains market size and forecasts of Furosemide in global, including the following market information:
Global Furosemide Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Furosemide Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Furosemide companies in 2021 (%)
The global Furosemide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Furosemide include Sanofi Aventis, US Pharm Holdings, Mylan, Sandoz, Hospira, West-Ward Pharms, Ivax Sub Teva Pharms, Emcure Pharms and Sun Pharm Inds. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Furosemide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Furosemide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Furosemide Market Segment Percentages, by Type, 2021 (%)
Injection
Solution
Tablet
Global Furosemide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Furosemide Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmacy
Clinics
Others
Global Furosemide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Furosemide Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Furosemide revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Furosemide revenues share in global market, 2021 (%)
Key companies Furosemide sales in global market, 2017-2022 (Estimated), (MT)
Key companies Furosemide sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi Aventis
US Pharm Holdings
Mylan
Sandoz
Hospira
West-Ward Pharms
Ivax Sub Teva Pharms
Emcure Pharms
Sun Pharm Inds
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
